Exact Mass: 843.3219512000001
Exact Mass Matches: 843.3219512000001
Found 16 metabolites which its exact mass value is equals to given mass value 843.3219512000001,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
(6S)-6-amino-N-[1-[3-[[4-[(2S)-2-amino-2-[4-[2-[[3-[1-[[(6S)-6-amino-3-oxoheptanoyl]amino]cyclopropyl]-3-oxopropanoyl]amino]acetyl]-1,3-thiazol-2-yl]acetyl]-1,3-thiazol-2-yl]methylamino]-3-oxopropanoyl]cyclopropyl]-3-oxoheptanamide
methyl 8-{[N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl]oxy}nonanoate
C35H59N2O21- (843.3610143999999)
methyl 8-{[N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl]oxy}nonanoate
C35H59N2O21- (843.3610143999999)
DDHepalpha1-6DDHepalpha1-2DDHepalpha1-2DDHepalphaO[CH2]3NH2
C31H57NO25 (843.3219512000001)
FC131 (TFA)
FC131 TFA is a CXCR4 antagonist, inhibits [125I]-SDF-1 binding to CXCR4, with an IC50 of 4.5 nM. Anti-HIV activity[1].
2-{15-[9-(3-bromo-4-hydroxyphenyl)nona-2,4,6,8-tetraenamido]-5,8,11,14-tetrahydroxy-9-(c-hydroxycarbonimidoylmethyl)-12-isopropyl-16-methyl-2-oxo-3-(sec-butyl)-1-oxa-4,7,10,13-tetraazacyclohexadeca-4,7,10,13-tetraen-6-yl}ethanimidic acid
C38H50BrN7O10 (843.2802340000001)
methyl (1r,2r,4s)-4-{[(2r,4s,5s,6s)-4-(dimethylamino)-5-{[(2s,4s,5s,6s)-4-hydroxy-5-{[(2r,3s,6s)-3-hydroxy-6-methyl-5-oxooxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl]oxy}-2-ethyl-2,5,7,12-tetrahydroxy-6,11-dioxo-3,4-dihydro-1h-tetracene-1-carboxylate
C42H53NO17 (843.3313327999999)
(2e,4e,6e,8e)-9-(3-bromo-4-hydroxyphenyl)-n-[5,8,11,14-tetrahydroxy-6,9-bis(c-hydroxycarbonimidoylmethyl)-12-isopropyl-16-methyl-2-oxo-3-(sec-butyl)-1-oxa-4,7,10,13-tetraazacyclohexadeca-4,7,10,13-tetraen-15-yl]nona-2,4,6,8-tetraenimidic acid
C38H50BrN7O10 (843.2802340000001)
2-{15-[9-(3-bromo-4-hydroxyphenyl)nona-2,4,6,8-tetraenamido]-5,8,11,14-tetrahydroxy-9-(c-hydroxycarbonimidoylmethyl)-12-isopropyl-16-methyl-3-(2-methylpropyl)-2-oxo-1-oxa-4,7,10,13-tetraazacyclohexadeca-4,7,10,13-tetraen-6-yl}ethanimidic acid
C38H50BrN7O10 (843.2802340000001)
(2e,4e,6e,8e)-9-(3-bromo-4-hydroxyphenyl)-n-[(3s,6s,9s,12s,15s,16r)-5,8,11,14-tetrahydroxy-6,9-bis(c-hydroxycarbonimidoylmethyl)-12-isopropyl-16-methyl-3-(2-methylpropyl)-2-oxo-1-oxa-4,7,10,13-tetraazacyclohexadeca-4,7,10,13-tetraen-15-yl]nona-2,4,6,8-tetraenimidic acid
C38H50BrN7O10 (843.2802340000001)
(2e,4e,6e,8e)-9-(3-bromo-4-hydroxyphenyl)-n-[(3s,6s,9s,12s,15s,16r)-3-[(2r)-butan-2-yl]-5,8,11,14-tetrahydroxy-6,9-bis(c-hydroxycarbonimidoylmethyl)-12-isopropyl-16-methyl-2-oxo-1-oxa-4,7,10,13-tetraazacyclohexadeca-4,7,10,13-tetraen-15-yl]nona-2,4,6,8-tetraenimidic acid
C38H50BrN7O10 (843.2802340000001)
2-[(2-{[2-({2-[(4-amino-8-{[(2,3-dihydroxyphenyl)(hydroxy)methylidene]amino}-1,3-dihydroxyoctylidene)amino]-1,3-dihydroxypropylidene}amino)-1-hydroxy-5-(n-hydroxyformamido)pentylidene]amino}-1-hydroxy-3-(c-hydroxycarbonimidoyl)propylidene)amino]-5-(n-hydroxyformamido)pentanoic acid
C34H53N9O16 (843.3610097999999)
(2s)-2-{[(2r)-2-{[(2s)-2-{[(2r)-2-{[(3s,4s)-4-amino-8-{[(2,3-dihydroxyphenyl)(hydroxy)methylidene]amino}-1,3-dihydroxyoctylidene]amino}-1,3-dihydroxypropylidene]amino}-1-hydroxy-5-(n-hydroxyformamido)pentylidene]amino}-1-hydroxy-3-(c-hydroxycarbonimidoyl)propylidene]amino}-5-(n-hydroxyformamido)pentanoic acid
C34H53N9O16 (843.3610097999999)